Article Information
History
- July 8, 2022.
Article Versions
- Version 1 (February 26, 2022 - 17:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jin Ge, MD, MBA1,*,
- Jean C. Digitale, MPH, RN2,
- Mark J. Pletcher, MD, MPH2,3,
- Jennifer C. Lai, MD, MBA1,
- the N3C Consortium
- 1Division of Gastroenterology and Hepatology, Department of Medicine, University of California – San Francisco, San Francisco, CA
- 2Department of Epidemiology and Biostatistics, University of California – San Francisco, San Francisco, CA
- 3Division of General Internal Medicine, Department of Medicine, University of California – San Francisco, San Francisco, CA
- ↵*Corresponding Author:
Jin Ge, MD, MBA, 513 Parnassus Avenue, S-357, San Francisco, CA 94143, E-mail: jin.ge{at}ucsf.edu, Fax: 415-476-0659
Posted July 08, 2022.
Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
